Linpei Jia

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Pharmaceutical biology

Expert opinion on therapeutic targets

BioMed research international

Journal of immunology research

Jilin University Second Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Jilin University Second Hospital Sep 01 2014 - Jun 30 2017

China

PHD :: Nephrology

Publications

Xingtong Dong, Jialing Zhang, Wen Li, Yinping Li, Linpei Jia, Zhaohui Liu, Wenjing Fu, Aihua Zhang
Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharmaceutical biology 62 (1) (2024)
Xingtong Dong, Jialing Zhang, Wen Li, Yinping Li, Linpei Jia, Zhaohui Liu, Wenjing Fu, Aihua Zhang
Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharmaceutical biology 62 (1) (2024)
Xingtong Dong, Jialing Zhang, Wen Li, Yinping Li, Linpei Jia, Zhaohui Liu, Wenjing Fu, Aihua Zhang
Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharmaceutical biology 62 (1) (2024)
Shan Liu, Wei Wei Zhang, Linpei Jia, Hong-Liang Zhang
Guillain-Barré syndrome: immunopathogenesis and therapeutic targets. Expert opinion on therapeutic targets (2024)
Xingtong Dong, Jialing Zhang, Wen Li, Yinping Li, Linpei Jia, Zhaohui Liu, Wenjing Fu, Aihua Zhang
Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharmaceutical biology 62 (1) (2024)
Shan Liu, Wei Wei Zhang, Linpei Jia, Hong-Liang Zhang
Guillain-Barré syndrome: immunopathogenesis and therapeutic targets. Expert opinion on therapeutic targets 28 (3) (2024)
Shan Liu, Wei Wei Zhang, Linpei Jia, Hong-Liang Zhang
Guillain‒barré syndrome: immunopathogenesis and therapeutic targets. Expert opinion on therapeutic targets (2024)
Hanxue Zhao, Peiyun Li, Hong-Liang Zhang, Linpei Jia
An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease. Renal failure 45 (2) (2023)
Linpei Jia, Hong-Liang Zhang
Plasma Exchange-Intravenous Immunoglobulin Synergy in the Treatment of Guillain-Barré Syndrome. Journal of child neurology 35 (5) (2020)
Liangmei Chen, Xiaomin Liu, Linpei Jia, Zhe-Yi Dong, Qian Wang, Yizhi Chen, Yong Wang, Ying Zheng, Sasa Nie, KangKang Song, Delong Zhao, Shuwei Duan, Zuoxiang Li, Zhe Feng, Xuefeng Sun, Guang-Yan Cai, Weiguang Zhang, Xiang-Mei Chen
Factors Associated with Brachial-Ankle Pulse Wave Velocity in an Apparently Healthy Chinese Population. BioMed research international 2020 (2020)
Haiyan Zhang, Zhuo Zhang, Linpei Jia, Wei Ji, Hai Li
Genetic Polymorphism in the RYR1 C6487T Is Associated with Severity of Hypospadias in Chinese Han Children. BioMed research international 2018 (2018)
Linpei Jia, Rufu Jia, Yinping Li, Xiaoxia Li, Qiang Jia, Hong-Liang Zhang
LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue. Journal of immunology research 2018 (2018)

Linpei Jia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Linpei Jia